Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) has announced a €5m investment in their Bern, Switzerland facility.
kp will expand capacity at its Swiss facility by 30% to address ever-changing market needs in EMEA and support expansion into Asia.
Tracey Peacock, President, Pharmaceutical & Medical Device Films at kp, says, “We are seeing substantial growth in our barrier product segments in EMEA in response to the increased moisture and oxygen sensitivity of new drugs. We are excited to add significant capacity to our Bern facility to support these trends in our market place.”
This latest investment comes less than 2 years after the addition of significant laminating capacity in EMEA with the expansion of the Pharmaceutical manufacturing center in Montabaur, Germany.
The new capacity will also support the Asian market as it continues to experience double-digit growth. Ms. Peacock went on to say, “We have been quietly adding to our capabilities in EMEA, and now we must accelerate addressing the growing Asian market place.
“Asia provides excellent opportunities for kp as regulation continues to increase with many EMEA and US standards being adopted. We are invigorated by the opportunities, and this expansion, supported by local manufacturing and slitting capability in Thailand and China, is just the beginning of some exciting plans we have.”
The new capability can be expected to be operational by the end of 2018 with the “simple aim of improving service to our customers wherever they may be in the world,” Peacock concluded.
To learn more about Klöckner Pentaplast and the pharmaceutical and medical device products, visit at the kp team at Booth A60 at Pharmapack Europe 2018, February 7-8, 2018, in Paris, France.